Effect of Acute Administration of Hypericum Perforatum-CO₂ Extract on Dopamine and Serotonin Release in the Rat Central Nervous System

The hydromethanolic extract of Hypericum perforatum has been shown to be an effective antidepressant, although its mechanism of action is still unclear. In this study, in vivo microdialysis was used to investigate the effects of Hypericum perforatum-CO₂ extract on dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), serotonin (5-HT), and 5-hydroxyindoleacetic acid (5-HIAA) release in various areas of brain. Administration of Hypericum perforatum extract (1 mg/kg, p.o.) caused a slight, but significant increase of DA outflow both in the nucleus accumbens and the striatum. The maximal increase of DA efflux (+ 19.22 ± 1.93 %, relative to the control group) in the nucleus accumbens occurred 100 min after administration of Hypericum perforatum. In the striatum, the extract maximally enhanced DA outflow (+ 24.83 ± 7.49 %, relative to the control group) 80 min after administration. Extraneuronal DOPAC levels were not significantly affected by Hypericum perforatum treatment. Moreover, Hypericum perforatum (1 mg/kg, p. o.) did not produce any significant effect on either 5-HT or 5-HIAA efflux in the ventral hippocampus. This study shows for the first time that Hypericum perforatum extract is capable of increasing in vivo DA release.

References

• 1 Bourin M, Baker G B. The future of antidepressants.  Biomed Pharmacother.. 1996;  50 7-12
• 2 Brolis M, Gabetta R, Fuzzati N, Pace R, Panzeri F, Peterlongo F. Identification by high-performance liquid chromatography-diode array detection-mass spectrometry and quantification by high-performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. .  J Chromatogr. . 1998;  825 9-16
• 3 Brown A S, Gershon S. Dopamine and depression.  J Neural Transm Gen Sec.. 1993;  91 75-109
• 4 Butterweck V, Wall A, Liefländer-Wulf U, Winterhoff H, Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.  Pharmacopsychiatry.. 1997;  30 (Supp. 2) 117-124
• 5 Cabib S, Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system.  Psychopharmacology.. 1996;  128 331-342
• 6 Cervo L, Grignaschi G, Samanin R. The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test.  Eur J Pharmacol.. 1990;  178 129-133
• 7 Cervo L, Samanin R. Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens.  J Pharm Pharmacol.. 1988;  40 155-156
• 8 Cervo L, Samanin R. Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test.  Neuropharmacology.. 1987;  26 1469-1472
• 9 Chatterjee S S, Bhattacharya S K, Singer A, Müller W E. Hyperforin as a possible antidepressant component of Hypericum extracts.  Life Sci.. 1998;  63 499-510
• 10 De Montis G M, Devoto P, Gessa L, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A. Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.  Eur J Pharmacol.. 1990;  180 31-35
• 11 De Smet P AGM, Nolen W A. 1996 St John's wort as an antidepressant.  Br Med J.. 1996;  313 241-242
• 12 Fibiger H C. Neurobiology of depression: focus on dopamine. In: Gessa G, Fratta W, Pani L, Serra G, (Eds), Depression and mania: from neurobiology to treatment. Raven Press, New York, NY 1995: 1-17
• 13 Fuller R W. Microdialysis studies with 5-HT reuptake inhibitors.  Trends Pharmacol Sci.. 1993;  14 397-398
• 14 Gambarana C, Ghiglieri O, Tolu P, De Montis M G, Giachetti D, Bombardelli E, Tagliamonte A. Efficacy of an Hypericum perforatum (St. John's Worth) extract in preventing and reverting a condition of escape deficit in rats.  Neuropsychopharmacology. 1999;  21 247-257
• 15 Kaehler S T, Sinner C, Chatterjee S S, Philippu A. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin, and glutamate in the rat locus coeruleus.  Neurosci Lett.. 1999;  262 199-202
• 16 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression - an overview and meta-analysis of randomised clinical trials.  Br Med J.. 1996;  313 253-258
• 17 Moghaddam B, Bunney B S. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine.  J Neurochem.. 1989;  53 652-654
• 18 Müller W E, Rolli M, Schäfer C, Hafner U. Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity.  Pharmacopsychiatry.. 1997;  30 (Suppl. 2) 102-107
• 19 Müller W E, Singer A, Wonnemann U, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract.  Pharmacopsychiatry.. 1998;  31 (Suppl. 1) 16-21
• 20 Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L.  Pharmacopsychiatry.. 1997;  30 (Suppl. 2) 129-134
• 21 Öztürk Y. Testing the antidepressant effects of Hypericum species on animal models.  Pharmacopsychiatry.. 1997;  30 (Suppl. 2) 125-128
• 22 Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY 1986
• 23 Plaznik A, Kostowski W. The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study.  Eur J Pharmacol.. 1987;  135 389-396
• 24 Puglisi-Allegra S, Imperato A, Angelucci L, Cabib S. Acute stress induces time-dependent responses in dopamine mesolimbic system.  Brain Res.. 1991;  554 217-222
• 25 Richelson E. Synaptic effects of antidepressants.  J Clin Psychopharmacol.. 1996;  (Suppl. 2) 16 1-7S
• 26 Volz H-P. Controlled clinical trials of hypericum extracts in depressed patients - an overview.  Pharmacopsychiatry.. 1997;  30 (Suppl. 2) 72-76